Hudson Bay Capital Management
EPZM

Hudson Bay Capital Management’s Epizyme, Inc EPZM Stock Holding History

Hudson Bay Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-225,000
Closed -$1.39M – 973
2018
Q4 		$1.39M Buy
225,000
+67,473
+43% +$515K 0.02% 586
2018
Q3 		$1.67M Buy
157,527
+82,481
+110% +$942K 0.02% 498
2018
Q2 		$1.02M Buy
75,046
+15,046
+25% +$234K 0.01% 628
2018
Q1 		$1.06M Sell
60,000
-65,000
-52% -$1.1M 0.02% 562
2017
Q4 		$1.57M Buy
+125,000
New +$1.82M 0.03% 354

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Hudson Bay Capital Management's EPZM Position: Q1 2019 in Review

Hudson Bay Capital Management sold out of Epizyme, Inc (EPZM) in Q1 2019, closing a stake of 225,000 shares — an estimated $1.39M sold.

Hudson Bay Capital Management first reported a position in EPZM in Q4 2017 and held it in 5 quarters. The position peaked at $1.67M in Q3 2018. 121 funds tracked by Wall St. Rank hold EPZM as of Q1 2019.

  • Hudson Bay Capital Management reported no remaining Epizyme, Inc position as of Q1 2019 after selling out during the quarter.
  • Hudson Bay Capital Management sold 225,000 Epizyme, Inc shares in Q1 2019, an estimated $1.39M.
  • Hudson Bay Capital Management first reported a position in Epizyme, Inc in Q4 2017 and held it in 5 quarters.
  • Hudson Bay Capital Management's Epizyme, Inc position peaked at $1.67M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2019.

Based on Hudson Bay Capital Management's 13F filing for Q1 2019, filed 15 May 2019.